Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
about
Clinical guidelines on the management of hepatitis CPatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesSustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibodyClinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patientsThe management of chronic hepatitis C virus infection.Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirinEffect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.Hepatitis C: progress and problems.Treatment of cirrhotic hepatitis C virus patients with daily doses of interferon-alpha 2a.Interferon treatment of chronic hepatitis C with cirrhosis.Real-time monitoring of HCV-RNA by single tube assay kit and potential importance for predicting virological sustained response in patients with chronic hepatitis C.The long-term efficacy of interferon alfa in chronic hepatitis C patients: a critical review.Screening asymptomatic people at high risk for hepatitis C. The case for.Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial.Pathomorphological study of HCV antibody-positive liver cirrhosis.Hepatitis C virus genotypes in multi-transfused individuals.Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
P2860
Q27477946-6CC26F70-241A-4596-A1C6-05D981DBA851Q27478466-C8CB6031-8629-41E1-9316-EC522B8F7C17Q27488912-26A290E5-783C-45BA-AAC8-7AE2AAD0681AQ27489398-951C536D-8207-41FD-8A92-ACE5C82957D9Q34408947-2472A6D0-F5E2-4D75-9EF1-5A64A9309EA3Q34409615-A3F58979-CD29-4716-87A9-AB2C77C01E36Q34521418-432F5852-C3D8-40CE-B7A2-A4DAF296DB6CQ35122264-75E2412B-51C9-475C-A106-8959FC25AF96Q35596873-4C6CE058-4C9E-4BC9-9B29-5E6683E63AE6Q36642065-D8CD790E-7428-45CA-9810-FF8588EF56A0Q40909905-88408EF9-F4C7-48BE-B6E0-7BF11EBB06F0Q40913738-D6EB720F-5091-4D26-A931-BB587388AEC3Q40931423-30F3E4DE-B0EB-4E5C-92B7-B567C8E99307Q40957762-22AAD3FD-7DF2-4611-B036-8A672200D678Q42261587-4FDDE07B-EEDC-403A-84F1-A30411C33375Q42994830-31AB0739-78BA-4926-B28E-AF91F9AEDDAAQ43036667-E83360A8-824E-4F4F-85CB-AE1A10B1FFABQ45335983-539702E2-27AB-4365-A446-BDAC46567E73Q46915103-ED6B8BEC-E1A6-4DAC-B4DF-2F42883197D2
P2860
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Long-term follow-up of patient ...... doses of interferon-alpha 2b.
@en
Long-term follow-up of patient ...... doses of interferon-alpha 2b.
@nl
type
label
Long-term follow-up of patient ...... doses of interferon-alpha 2b.
@en
Long-term follow-up of patient ...... doses of interferon-alpha 2b.
@nl
prefLabel
Long-term follow-up of patient ...... doses of interferon-alpha 2b.
@en
Long-term follow-up of patient ...... doses of interferon-alpha 2b.
@nl
P2093
P1433
P1476
Long-term follow-up of patient ...... doses of interferon-alpha 2b.
@en
P2093
A Di Napoli
L Chiandussi
P304
P356
10.1016/0270-9139(93)90215-9
P407
P577
1993-12-01T00:00:00Z